Safety and Preliminary Efficacy in Patients with Relapsed/Refractory Mantle Cell Lymphoma Receiving Lisocabtagene Maraleucel in Transcend NHL 001

被引：54
|
作者：
Palomba, Maria Lia
Gordon, Leo I.
Siddiqi, Tanya
Abramson, Jeremy S.
Kamdar, Manali
Lunning, Matthew A.
Maloney, David G.
Andreadis, Charalambos
Arnason, Jon E.
Ghosh, Nilanjan
Mehta, Amitkumar
Solomon, Scott R.
Farazi, Thalia
Garcia, Jacob
Dehner, Christine
Ogasawara, Ken
Gao, Jie
Wang, Michael
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-136158
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Safety and Preliminary Efficacy in Patients With Relapsed/Refractory Mantle Cell Lymphoma Receiving Lisocabtagene Maraleucel in TRANSCEND NHL 001
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (04) : 10 - 11
  • [2] Safety and Preliminary Efficacy in Patients With Relapsed/Refractory Mantle Cell Lymphoma Receiving Lisocabtagene Maraleucel (Liso-Cel) in TRANSCEND NHL 001
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (08) : 8 - 9
  • [3] Safety and preliminary efficacy in patients (pts) with relapsed/refractory (R/R) mantle cell lymphoma (MCL) receiving lisocabtagene maraleucel (Liso-cel) in TRANSCEND NHL 001.
    Wang, Michael
    Gordon, Leo I.
    Palomba, Maria Lia
    Abramson, Jeremy S.
    Andreadis, Charalambos
    Ghosh, Nilanjan
    Lunning, Matthew Alexander
    Maloney, David G.
    Farazi, Thalia Andrea
    Garcia, Jacob
    Xie, Benhuai
    Newhall, Kathryn J.
    Dehner, Christine
    Siddiqi, Tanya
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study
    Wang, Michael
    Siddiqi, Tanya
    Gordon, Leo I.
    Kamdar, Manali
    Lunning, Matthew
    Hirayama, Alexandre V.
    Abramson, Jeremy S.
    Arnason, Jon
    Ghosh, Nilanjan
    Mehta, Amitkumar
    Andreadis, Charalambos
    Solomon, Scott R.
    Kostic, Ana
    Dehner, Christine
    Espinola, Ricardo
    Peng, Lily
    Ogasawara, Ken
    Chattin, Amy
    Eliason, Laurie
    Palomba, M. Lia
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (10) : 1146 - 1157
  • [5] Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001
    Abramson, Jeremy S.
    Palomba, M. Lia
    Gordon, Leo I.
    Lunning, Matthew
    Wang, Michael
    Arnason, Jon
    Purev, Enkhtsetseg
    Maloney, David G.
    Andreadis, Charalambos
    Sehgal, Alison
    Solomon, Scott R.
    Ghosh, Nilanjan
    Dehner, Christine
    Kim, Yeonhee
    Ogasawara, Ken
    Kostic, Ana
    Siddiqi, Tanya
    BLOOD, 2024, 143 (05) : 404 - 416
  • [6] Safety and efficacy results from TRANSCEND NHL 001, a multicenter phase 1 study of lisocabtagene maraleucel (liso-cel) in relapsed/refractory large B-cell lymphoma
    Abramson, J.
    Palomba, M. L.
    Gordon, L.
    Lunning, M.
    Wang, M.
    Arnason, J.
    Mehta, A.
    Purev, E.
    Maloney, D.
    Andreadis, C.
    Sehgal, A.
    Solomon, S.
    Ghosh, N.
    Albertson, T.
    Garcia, J.
    Kostic, A.
    Li, D.
    Kim, Y.
    Siddiqi, T.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 94 - 95
  • [7] Safety and Efficacy Results From Transcend NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel (Liso-cel) In Relapsed/refractory Large B-Cell Lymphoma
    Abramson, Jeremy
    Palomba, M. Lia
    Gordon, Leo
    Lunning, Matthew
    Wang, Michael
    Arnason, Jon
    Mehta, Amitkumar
    Purev, Enkhtsetseg
    Maloney, David
    Andreadis, Charalambos
    Sehgal, Alison
    Solomon, Scott
    Ghosh, Nilanjan
    Albertson, Tina
    Garcia, Jacob
    Kostic, Ana
    Li, Daniel
    Kim, Yeonhee
    Siddiqi, Tanya
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 43 - 44
  • [8] Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
    Abramson, Jeremy S.
    Palomba, M. Lia
    Gordon, Leo I.
    Lunning, Matthew A.
    Wang, Michael
    Arnason, Jon
    Mehta, Amitkumar
    Purev, Enkhtsetseg
    Maloney, David G.
    Andreadis, Charalambos
    Sehgal, Alison
    Solomon, Scott R.
    Ghosh, Nilanjan
    Albertson, Tina M.
    Garcia, Jacob
    Kostic, Ana
    Mallaney, Mary
    Ogasawara, Ken
    Newhall, Kathryn
    Kim, Yeonhee
    Li, Daniel
    Siddiqi, Tanya
    LANCET, 2020, 396 (10254): : 839 - 852
  • [9] Pivotal Safety and Efficacy Results From TRANSCEND NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel in Relapsed/Refractory Large B-Cell Lymphomas
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (02) : 8 - 10
  • [10] Estimating the health care costs associated with receipt of lisocabtagene maraleucel: Insights from adults with mantle cell lymphoma (TRANSCEND NHL 001)
    Phillips, Tycel Jovelle
    Martin, Ashley
    Lee, Abraham D.
    Mirza, Sana
    Carattini, Thomas
    McGarvey, November H.
    Patwardhan, Pallavi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345